.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Fish and Richardson
McKesson
Cipla
Covington
Mallinckrodt
Dow
QuintilesIMS
Harvard Business School
Daiichi Sankyo

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022207

« Back to Dashboard
NDA 022207 describes MORPHINE SULFATE, which is a drug marketed by Novel Labs Inc, Upsher Smith, Dava Pharms Inc, West-ward Pharms Int, Hospira, Vintage Pharms Llc, Impax Labs Inc, Nostrum Labs Inc, Par Pharm Inc, Mallinckrodt, Hospira Inc, Icu Medical Inc, Lannett Holdings Inc, Teva Pharms Usa, Tris Pharma Inc, Rhodes Pharms, Nesher Pharms, Fresenius Kabi Usa, Mylan Pharms Inc, Mallinckrodt Inc, Sun Pharm Inds, Actavis Elizabeth, Vistapharm, Watson Labs, Epic Pharma Llc, Eurohlth Intl Sarl, Sun Pharm Inds Ltd, Pharm Assoc, Paddock Llc, Mayne Pharma Inc, and Meridian Medcl Techn, and is included in fifty-one NDAs. It is available from forty-seven suppliers. There are three patents protecting this drug. Additional details are available on the MORPHINE SULFATE profile page.

The generic ingredient in MORPHINE SULFATE is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for NDA: 022207

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 022207

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 022207

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MORPHINE SULFATE
morphine sulfate
TABLET;ORAL 022207 NDA West-Ward Pharmaceuticals Corp 0054-0235 0054-0235-24 4 BLISTER PACK in 1 CARTON (0054-0235-24) > 25 TABLET in 1 BLISTER PACK
MORPHINE SULFATE
morphine sulfate
TABLET;ORAL 022207 NDA West-Ward Pharmaceuticals Corp 0054-0235 0054-0235-25 100 TABLET in 1 BOTTLE (0054-0235-25)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Mar 17, 2008TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength30MG
Approval Date:Mar 17, 2008TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Medtronic
Citi
Farmers Insurance
Colorcon
McKesson
Julphar
Dow
Chinese Patent Office
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot